Biobehavioral Intervention for Testicular Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new therapy called Goal-focused Emotion-Regulation Therapy (GET) for young adults who have had testicular cancer. The aim is to determine if GET can reduce distress, improve emotional regulation, and enhance skills in setting and achieving personal goals. Participants will either try GET or engage in supportive listening sessions (Individual Supportive Listening Therapy) over eight weeks to compare effects. This trial suits those aged 18 to 39 who completed chemotherapy for testicular cancer in the last four years and frequently experience distress, as measured by a simple screening tool. As an unphased trial, it offers a unique opportunity to explore innovative therapy options that could enhance emotional well-being and goal achievement.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this biobehavioral intervention is safe for young adult testicular cancer patients?
A previous study found Goal-Focused Emotion-Regulation Therapy (GET) to be a practical and well-liked method for helping young adults with testicular cancer manage stress and enhance emotional skills. Participants appreciated the therapy, which caused no major problems or side effects.
Similarly, Individual Supportive Listening (ISL) emphasizes careful listening and encourages self-expression. It aims to help individuals manage stress and boost self-esteem. Reports indicate no negative effects from ISL, making it a safe choice.
Both treatments are non-invasive and aim to improve mental well-being, generally posing a low risk of harm.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for testicular cancer because they address emotional well-being in unique ways. Unlike traditional approaches that focus primarily on medical or physical symptoms, Goal-Focused Emotion-Regulation Therapy (GET) helps young adults improve their emotional resilience by enhancing goal-setting skills and emotional regulation. Individual Supportive Listening offers a non-directive space for patients to express their feelings, promoting self-esteem and stress management. Together, these interventions aim to provide a more holistic approach to patient care, potentially leading to improved quality of life for those undergoing treatment for testicular cancer.
What evidence suggests that this trial's treatments could be effective for testicular cancer patients?
Research shows that Goal-Focused Emotion-Regulation Therapy (GET), one of the treatments in this trial, helps young adults with testicular cancer by reducing distress and enhancing their ability to manage emotions and set goals. Studies have found that GET is practical and well-received by these patients, yielding promising results. In contrast, Individual Supportive Listening (ISL), another treatment option in this trial, is a common method in cancer care that aids patients in handling stress through attentive listening and support. While ISL is a well-known approach, GET may better improve emotion management and overall well-being. Both treatments in this trial aim to help patients navigate emotional challenges during and after cancer treatment.12356
Who Is on the Research Team?
Michael A Hoyt, PhD
Principal Investigator
University of California, Irvine
Are You a Good Fit for This Trial?
This trial is for young adults aged 18-39 who have had testicular cancer and finished chemotherapy within the last 4 years. They must be fluent in English or Spanish, feel distressed (scoring >4 on a Distress Thermometer), and be able to consent. It's not for regular smokers, those with immune-affecting conditions, recent heart attacks or strokes, Type I diabetes, acute hepatitis, recent vaccinations, or a history of psychiatric or cognitive disturbances.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive six sessions of Goal-focused Emotion-Regulation Therapy (GET) or Individual Supportive Listening (ISL) over eight weeks
Follow-up
Participants are monitored for psychological and biobehavioral outcomes post-treatment
What Are the Treatments Tested in This Trial?
Interventions
- Goal-Focused Emotion-Regulation Therapy (GET)
- Individual Supportive Listening
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Irvine
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
Memorial Sloan Kettering Cancer Center
Collaborator